In this study, we evaluated whether our LNP-siRNA strategy also permits endothelium-specific silencing of Vwf under conditions of hypercholesterolemia and a diseased vasculature prone to developing atherothrombosis. This evidence concerns the gene VWF and familial hypercholesterolemia.